Published in Lancet on August 16, 1980
In vitro sensitivity of human ovarian tumours to chemotherapeutic agents. Br J Cancer (1981) 1.11
Limitations of the clonal agar assay for the assessment of primary human ovarian tumour biopsies. Br J Cancer (1982) 1.10
A feasibility study of the MTT assay for chemosensitivity testing in ovarian malignancy. Br J Cancer (1990) 0.89
Role of laboratory chemosensitivity testing in the selection of cancer chemotherapy for individual patients. J Clin Pathol (1981) 0.82
Reliability of tumor primary cultures as a model for drug response prediction: expression profiles comparison of tissues versus primary cultures from colorectal cancer patients. J Cancer Res Clin Oncol (2011) 0.78
Prediction of Cancer Drug Resistance and Implications for Personalized Medicine. Front Oncol (2015) 0.77
Soft agarose culture human tumour colony forming assay for drug sensitivity testing: [3H]-thymidine incorporation vs colony counting. Br J Cancer (1985) 0.76
Clinical correlates of in vitro drug sensitivities of ovarian cancer cells. Br J Cancer (1983) 0.75
Cancer chemotherapy: past, present, and future--Part II. J Natl Med Assoc (1984) 0.75
Obstetrics and gynecology-epitomes of progress: ovarian carcinoma: in vitro testing of sensitivity to chemotherapy. West J Med (1981) 0.75
British Association for Cancer Research 22nd Annual general meeting. 13-15 April 1981. Abstracts. Br J Cancer (1981) 0.75
Time course of ovarian tumour growth in soft agar culture. Br J Cancer (1985) 0.75
Optimal chemotherapy for ovarian carcinoma: discussion paper. J R Soc Med (1984) 0.75
Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells. PLoS One (2017) 0.75
The metabolism of naphthalene in rabbits. Biochem J (1934) 31.93
Synthesis of l-alpha-naphthylmercapturic acid. Biochem J (1934) 12.42
A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature (1993) 8.29
A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med (1995) 6.14
Genetic control of programmed cell death in Drosophila. Science (1994) 6.08
Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol (2000) 6.06
Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs. N Engl J Med (1978) 5.78
Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science (1996) 5.55
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol (1990) 3.54
Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4. Experientia (1989) 2.90
Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc Natl Acad Sci U S A (1991) 2.61
Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature (1998) 2.59
Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron (1992) 2.54
Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma. J Virol (1990) 2.43
Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation. Nat Neurosci (2000) 2.24
Direct cloning of human ovarian carcinoma cells in agar. Cancer Res (1978) 2.24
Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med (2000) 2.14
Colon cancer reduction. Questions about implementation of proven techniques. Arch Intern Med (1997) 2.12
Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis (2008) 2.12
Self-reported prevalence of asthma symptoms in children in Australia, England, Germany and New Zealand: an international comparison using the ISAAC protocol. Eur Respir J (1993) 2.07
Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J Natl Cancer Inst (1994) 2.05
Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am J Pathol (1988) 2.01
Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res (1997) 1.96
Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res (1995) 1.94
Biochemical studies of toxic agents. Metabolic ring-fission of cis- and trans-acenaphthene-1,2-diol. Biochem J (1966) 1.91
Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalin-fixed paraffin sections. J Histochem Cytochem (1993) 1.91
Enterobactin-mediated iron transport in Pseudomonas aeruginosa. J Bacteriol (1990) 1.90
Adenoma characteristics as risk factors for recurrence of advanced adenomas. Gastroenterology (2001) 1.88
Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol Biomarkers Prev (2001) 1.87
Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma. Cancer (1976) 1.85
Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett (1992) 1.79
Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein. Cancer Res (1986) 1.75
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
How to influence patient oral hygiene behavior effectively. J Dent Res (2009) 1.63
Increased mRNA expression of a laminin-binding protein in human colon carcinoma: complete sequence of a full-length cDNA encoding the protein. Proc Natl Acad Sci U S A (1988) 1.62
Time-resolved pump-probe experiments at the LCLS. Opt Express (2010) 1.61
Biochemical studies of toxic agents. The metabolic formation of 1- and 2-menaphthylmercapturic acid. Biochem J (1968) 1.61
Biochemical studies of toxic agents. 15. The biosynthesis of ethylmercapturic acid sulphoxide. Biochem J (1964) 1.59
Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. N Engl J Med (1979) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Enabling households to support successful migration of AIDS orphans in southern Africa. AIDS Care (2004) 1.55
The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene. Nat Genet (1994) 1.52
Outcomes in African Americans and Hispanics with lupus nephritis. Kidney Int (2006) 1.52
Dose response evaluation of adriamycin in human neoplasia. Cancer (1977) 1.51
Antigen retrieval immunohistochemistry under the influence of pH using monoclonal antibodies. J Histochem Cytochem (1995) 1.50
Identification of two cysteine residues that are required for redox modulation of the NMDA subtype of glutamate receptor. Neuron (1994) 1.50
Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology (2001) 1.50
Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines. Anticancer Drugs (1996) 1.49
A novel gene, AF1q, fused to MLL in t(1;11) (q21;q23), is specifically expressed in leukemic and immature hematopoietic cells. Blood (1995) 1.48
Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol (2001) 1.47
Analogues of amonafide and azonafide with novel ring systems. J Med Chem (2000) 1.47
Current practices and intention to provide alcohol-related health advice in primary dental care. Br Dent J (2011) 1.46
Studies on the biologic relationship of some murine leukemia viruses. Cancer Res (1966) 1.46
A national policy on asthma management for schools. The Asthma Special Interest Group, Thoracic Society of Australia and New Zealand. J Paediatr Child Health (1994) 1.45
Effect of beta-carotene on lymphocyte subpopulations in elderly humans: evidence for a dose-response relationship. Am J Clin Nutr (1991) 1.45
Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. Cancer Treat Rep (1976) 1.45
Management of hypercholesterolemia: practice patterns for primary care providers and cardiologists. Am J Cardiol (1997) 1.45
Superior rectal artery injury following lumbar disc surgery. Case report. J Neurosurg (2001) 1.43
Formation of mercapturic acids in rats after the administration of aralkyl esters. Biochem J (1970) 1.43
Reliability and validity of a self-administered food frequency questionnaire in a chemoprevention trial of adenoma recurrence. Cancer Epidemiol Biomarkers Prev (1999) 1.42
Randomized phase II study of BR96-doxorubicin conjugate in patients with metastatic breast cancer. J Clin Oncol (1999) 1.41
Pyochelin-mediated iron transport in Pseudomonas aeruginosa: involvement of a high-molecular-mass outer membrane protein. Infect Immun (1991) 1.41
Rabies encephalitis in a patient with no history of exposure. Hum Pathol (1993) 1.38
GM-CSF, carboplatin, doxorubicin: a phase I study. Cancer Chemother Pharmacol (1994) 1.38
A mutation in the human ryanodine receptor gene associated with central core disease. Nat Genet (1993) 1.37
The role of focus groups in health education for cervical cancer among minority women. J Community Health (1990) 1.37
Comparison of bone scintigraphy and radiography in multiple myeloma. Radiology (1980) 1.37
Initial experience with the Pascal photocoagulator: a pilot study of 75 procedures. Br J Ophthalmol (2008) 1.37
The risk for transmission of Mycobacterium tuberculosis at the bedside and during autopsy. Ann Intern Med (1995) 1.36
Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treat Rep (1980) 1.35
The DNA sequence and analysis of human chromosome 13. Nature (2004) 1.33
The factor structure of self-report DSM-III axis II symptoms and their relationship to clinicians' ratings. Am J Psychiatry (1990) 1.32
Laparoscopically assisted surgical staging (LASS) of endometrial cancer. Gynecol Oncol (1993) 1.31
Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol (1998) 1.29
Characterization of a new human endometrial carcinoma (RL95-2) established in tissue culture. In Vitro (1983) 1.29
Canadian Researches on BAL (British Anti-Lewisite). Science (1946) 1.27
Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group. Br J Cancer (1998) 1.27
Guest-host interactions investigated by time-resolved X‑ray spectroscopies and scattering at MHz rates: solvation dynamics and photoinduced spin transition in aqueous Fe(bipy)3(2+). J Phys Chem A (2012) 1.26
Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer. J Clin Oncol (1992) 1.26
New oral anticoagulants: a practical guide on prescription, laboratory testing and peri-procedural/bleeding management. Australasian Society of Thrombosis and Haemostasis. Intern Med J (2014) 1.25
Measurement of chemopreventive efficacy in skin biopsies. Anal Quant Cytol Histol (2001) 1.25
Nonlinear atomic response to intense ultrashort x rays. Phys Rev Lett (2011) 1.24
Asthma under-recognition and under-treatment in an Australian community. Aust N Z J Med (1992) 1.24
Microstructure of fragile metallic glasses inferred from ultrasound-accelerated crystallization in Pd-based metallic glasses. Phys Rev Lett (2005) 1.24
Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 1.23
Dose de-escalation chemoprevention trial of alpha-difluoromethylornithine in patients with colon polyps. J Natl Cancer Inst (1994) 1.23
Characterization and epitope mapping of a human monoclonal antibody reactive with the envelope glycoprotein of human immunodeficiency virus. J Immunol (1987) 1.22
High-dose dexamethasone for prevention of cis-platin-induced vomiting. Cancer Chemother Pharmacol (1981) 1.21
Lipid peroxidation: a possible role in the induction and progression of chronic periodontitis. J Periodontal Res (2005) 1.21
Attitudes and practices of primary care physicians for prostate cancer screening. Am J Prev Med (1997) 1.21
DNA sequence and analysis of human chromosome 9. Nature (2004) 1.21
The interaction of sulphate esters and glutathione in vivo. Biochem J (1970) 1.21
Central oxytocin and reproductive behaviours. Rev Reprod (1997) 1.20
Karyometry in the early detection and chemoprevention of intraepithelial lesions. Eur J Cancer (2005) 1.20